Gross Profit Summary of ResMed Inc.

ResMed Inc.'s latest annual gross profit in 2024 was 2.6 Billion USD , up 12.72% from previous year.
ResMed Inc.'s latest quarterly gross profit in 2024 FY was 2.6 Billion USD , up 10.75% from previous quarter.
ResMed Inc. reported a annual gross profit of 2.35 Billion USD in annual gross profit 2023, up 16.37% from previous year.
ResMed Inc. reported a annual gross profit of 2.02 Billion USD in annual gross profit 2022, up 10.07% from previous year.
ResMed Inc. reported a quarterly gross profit of 704.26 Million USD for 2024 Q4, up 3.33% from previous quarter.
ResMed Inc. reported a quarterly gross profit of 2.6 Billion USD for 2024 FY, up 10.75% from previous quarter.

Annual Gross Profit Chart of ResMed Inc. (2024 - 1993)

Historical Annual Gross Profit of ResMed Inc. (2024 - 1993)

Year	Gross Profit	Gross Profit Growth
2024	2.6 Billion USD	12.72%
2023	2.35 Billion USD	16.37%
2022	2.02 Billion USD	10.07%
2021	1.83 Billion USD	7.06%
2020	1.71 Billion USD	11.79%
2019	1.53 Billion USD	12.8%
2018	1.36 Billion USD	13.35%
2017	1.2 Billion USD	12.68%
2016	1.06 Billion USD	5.45%
2015	1.01 Billion USD	2.18%
2014	989.78 Million USD	5.22%
2013	940.65 Million USD	14.61%
2012	820.73 Million USD	10.71%
2011	741.32 Million USD	13.1%
2010	655.48 Million USD	18.36%
2009	553.8 Million USD	12.16%
2008	493.75 Million USD	28.42%
2007	384.49 Million USD	2.02%
2006	376.89 Million USD	37.12%
2005	274.86 Million USD	26.82%
2004	216.73 Million USD	25.22%
2003	173.08 Million USD	29.9%
2002	133.24 Million USD	27.17%
2001	104.77 Million USD	23.46%
2000	84.87 Million USD	33.03%
1999	63.8 Million USD	35.46%
1998	47.1 Million USD	49.52%
1997	31.5 Million USD	66.67%
1996	18.9 Million USD	47.66%
1995	12.8 Million USD	60.0%
1994	8 Million USD	66.67%
1993	4.8 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	646.93 Million USD	7.81%
2024 Q4	704.26 Million USD	3.33%
2024 FY	2.6 Billion USD	10.75%
2024 Q3	681.57 Million USD	5.35%
2024 Q1	600.06 Million USD	-2.81%
2023 FY	2.35 Billion USD	16.37%
2023 Q3	617.75 Million USD	6.56%
2023 Q4	617.38 Million USD	-0.06%
2023 Q2	579.71 Million USD	7.19%
2023 Q1	540.81 Million USD	3.5%
2022 Q1	506.28 Million USD	3.18%
2022 Q3	491.19 Million USD	-2.6%
2022 FY	2.02 Billion USD	10.07%
2022 Q4	522.5 Million USD	6.37%
2022 Q2	504.31 Million USD	-0.39%
2021 FY	1.83 Billion USD	7.06%
2021 Q4	490.69 Million USD	9.71%
2021 Q2	462.48 Million USD	5.43%
2021 Q1	438.66 Million USD	-2.38%
2021 Q3	447.25 Million USD	-3.29%
2020 Q3	449.66 Million USD	5.28%
2020 FY	1.71 Billion USD	11.79%
2020 Q4	449.37 Million USD	-0.06%
2020 Q1	405.05 Million USD	-3.06%
2020 Q2	427.13 Million USD	5.45%
2019 Q2	383.73 Million USD	11.84%
2019 FY	1.53 Billion USD	12.8%
2019 Q4	417.85 Million USD	6.62%
2019 Q1	343.09 Million USD	-5.35%
2019 Q3	391.91 Million USD	2.13%
2018 Q4	362.47 Million USD	5.28%
2018 FY	1.36 Billion USD	13.35%
2018 Q3	344.29 Million USD	-1.57%
2018 Q2	349.79 Million USD	14.46%
2018 Q1	305.6 Million USD	-5.61%
2017 Q2	309.07 Million USD	14.82%
2017 Q3	299.71 Million USD	-3.03%
2017 FY	1.2 Billion USD	12.68%
2017 Q4	323.77 Million USD	8.03%
2017 Q1	269.18 Million USD	-10.72%
2016 Q2	266.5 Million USD	11.69%
2016 FY	1.06 Billion USD	5.45%
2016 Q3	259.88 Million USD	-2.49%
2016 Q4	301.48 Million USD	16.01%
2016 Q1	238.61 Million USD	-8.02%
2015 Q4	259.43 Million USD	3.18%
2015 Q3	251.43 Million USD	-4.48%
2015 Q1	237.31 Million USD	-9.17%
2015 FY	1.01 Billion USD	2.18%
2015 Q2	263.22 Million USD	10.92%
2014 FY	989.78 Million USD	5.22%
2014 Q4	261.25 Million USD	3.76%
2014 Q1	227.98 Million USD	-12.26%
2014 Q2	248.75 Million USD	9.11%
2014 Q3	251.78 Million USD	1.22%
2013 FY	940.65 Million USD	14.61%
2013 Q1	208.64 Million USD	-7.87%
2013 Q2	232.71 Million USD	11.53%
2013 Q4	259.84 Million USD	8.52%
2013 Q3	239.44 Million USD	2.89%
2012 Q3	210.49 Million USD	5.93%
2012 FY	820.73 Million USD	10.71%
2012 Q1	185.05 Million USD	-6.95%
2012 Q2	198.71 Million USD	7.38%
2012 Q4	226.46 Million USD	7.59%
2011 Q2	185.99 Million USD	6.92%
2011 Q3	542.45 Million USD	191.64%
2011 Q4	198.87 Million USD	-63.34%
2011 FY	741.32 Million USD	13.1%
2011 Q1	173.95 Million USD	-0.32%
2010 FY	655.48 Million USD	18.36%
2010 Q1	150.17 Million USD	-4.17%
2010 Q2	164.2 Million USD	9.34%
2010 Q3	166.58 Million USD	1.45%
2010 Q4	174.51 Million USD	4.76%
2009 Q3	138.94 Million USD	6.04%
2009 Q2	131.02 Million USD	3.07%
2009 Q4	156.7 Million USD	12.79%
2009 Q1	127.12 Million USD	-5.19%
2009 FY	553.8 Million USD	12.16%
2008 Q1	111.77 Million USD	-4.63%
2008 FY	493.75 Million USD	28.42%
2008 Q4	134.08 Million USD	5.95%
2008 Q3	126.55 Million USD	4.31%
2008 Q2	121.33 Million USD	8.55%
2007 Q1	101.29 Million USD	-2.77%
2007 Q2	111.75 Million USD	10.33%
2007 FY	384.49 Million USD	2.02%
2007 Q4	117.2 Million USD	116.12%
2007 Q3	54.23 Million USD	-51.47%
2006 Q3	100.86 Million USD	9.96%
2006 Q4	104.18 Million USD	3.29%
2006 Q2	91.72 Million USD	14.49%
2006 Q1	80.11 Million USD	0.43%
2006 FY	376.89 Million USD	37.12%
2005 Q2	68.37 Million USD	21.21%
2005 Q1	56.41 Million USD	-5.36%
2005 FY	274.86 Million USD	26.82%
2005 Q4	79.77 Million USD	13.49%
2005 Q3	70.29 Million USD	2.8%
2004 Q1	47.15 Million USD	-6.37%
2004 Q2	52.42 Million USD	11.17%
2004 FY	216.73 Million USD	25.22%
2004 Q4	59.6 Million USD	3.57%
2004 Q3	57.55 Million USD	9.78%
2003 Q2	41.83 Million USD	10.99%
2003 Q3	43.18 Million USD	3.22%
2003 Q4	50.36 Million USD	16.62%
2003 FY	173.08 Million USD	29.9%
2003 Q1	37.69 Million USD	2.42%
2002 FY	133.24 Million USD	27.17%
2002 Q3	33.77 Million USD	6.07%
2002 Q1	30.83 Million USD	18.41%
2002 Q2	31.83 Million USD	3.26%
2002 Q4	36.8 Million USD	8.99%
2001 Q4	26.04 Million USD	-15.7%
2001 FY	104.77 Million USD	23.46%
2001 Q3	30.88 Million USD	24.55%
2001 Q2	24.8 Million USD	7.59%
2001 Q1	23.05 Million USD	0.48%
2000 Q2	21 Million USD	9.95%
2000 Q3	21.77 Million USD	3.71%
2000 Q4	22.94 Million USD	5.34%
2000 FY	84.87 Million USD	33.03%
2000 Q1	19.1 Million USD	6.7%
1999 Q1	14.1 Million USD	2.17%
1999 Q2	15.6 Million USD	10.64%
1999 Q3	16 Million USD	2.56%
1999 Q4	17.9 Million USD	11.88%
1999 FY	63.8 Million USD	35.46%
1998 Q1	9.5 Million USD	3.26%
1998 Q3	12.2 Million USD	5.17%
1998 Q4	13.8 Million USD	13.11%
1998 FY	47.1 Million USD	49.52%
1998 Q2	11.6 Million USD	22.11%
1997 FY	31.5 Million USD	66.67%
1997 Q3	8.1 Million USD	8.0%
1997 Q4	9.2 Million USD	13.58%
1997 Q1	6.7 Million USD	8.06%
1997 Q2	7.5 Million USD	11.94%
1996 FY	18.9 Million USD	47.66%
1996 Q3	4.8 Million USD	-39.24%
1996 Q4	6.2 Million USD	29.17%
1996 Q1	6.7 Million USD	0.0%
1996 Q2	7.9 Million USD	17.91%
1995 Q2	5.6 Million USD	0.0%
1995 Q3	5.6 Million USD	0.0%
1995 FY	12.8 Million USD	60.0%
1995 Q4	6.7 Million USD	19.64%
1995 Q1	5.6 Million USD	64.71%
1994 Q4	3.4 Million USD	-2.86%
1994 FY	8 Million USD	66.67%
1994 Q1	3.5 Million USD	75.0%
1994 Q3	3.5 Million USD	0.0%
1994 Q2	3.5 Million USD	0.0%
1993 Q2	1.9 Million USD	0.0%
1993 FY	4.8 Million USD	0.0%
1993 Q3	1.9 Million USD	0.0%
1993 Q1	1.9 Million USD	0.0%
1993 Q4	2 Million USD	5.26%

Peer Gross Profit Comparison of ResMed Inc.

Name	Gross Profit	Gross Profit Difference
Alcon Inc.	5.6 Billion USD	53.481%
AptarGroup, Inc.	1.26 Billion USD	-106.489%
Baxter International Inc.	4.97 Billion USD	47.562%
Becton, Dickinson and Company	9.15 Billion USD	71.498%
Bausch + Lomb Corporation	2.5 Billion USD	-4.185%
Haemonetics Corporation	676.53 Million USD	-285.608%
Envista Holdings Corp	1.45 Billion USD	-79.854%
Teleflex Incorporated	1.64 Billion USD	-58.403%
Warby Parker Inc.	365.22 Million USD	-614.296%
West Pharmaceutical Services, Inc.	1.12 Billion USD	-131.029%

Global Stocks Search

ResMed Inc. (RMD)

Gross Profit Summary of ResMed Inc.

Annual Gross Profit Chart of ResMed Inc. (2024 - 1993)

Historical Annual Gross Profit of ResMed Inc. (2024 - 1993)

Peer Gross Profit Comparison of ResMed Inc.